Smith Shellnut Wilson LLC Bristol Myers Squibb CO Transaction History
Smith Shellnut Wilson LLC
- $215 Million
- Q1 2025
A detailed history of Smith Shellnut Wilson LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Smith Shellnut Wilson LLC holds 3,524 shares of BMY stock, worth $170,667. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,524Holding current value
$170,667% of portfolio
0.1%Shares
10 transactions
Others Institutions Holding BMY
# of Institutions
2,738Shares Held
1.59BCall Options Held
25.8MPut Options Held
23.9M-
Vanguard Group Inc Valley Forge, PA191MShares$9.27 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.68 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$5.23 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.59 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.22 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $103B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...